Anesthesia and Non-small Cell Lung Cancer Recurrence

NCT06330038 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5384

Last updated 2026-04-20

No results posted yet for this study

Summary

There has been ongoing debate about the relationship between cancer recurrence and anesthetic management. Therefore, the investigators will test the hypothesis that the recurrence free survival (RFS) after curative resection of NSCLC is higher in patient who received total intravenous anesthesia (TIVA) than volatile anesthetics in this multi-center randomized trials.

Conditions

Interventions

DRUG

Propofol

Propofol will be used for the induction and maintenance of general anesthesia.

DRUG

Inhaled anesthetics

Inhaled anesthetics will be used for the maintenance of general anesthesia.

Sponsors & Collaborators

  • Seoul National University Hospital

    collaborator OTHER
  • Asan Medical Center

    collaborator OTHER
  • Severance Hospital

    collaborator OTHER
  • Seoul St. Mary's Hospital

    collaborator OTHER
  • Korea University Guro Hospital

    collaborator OTHER
  • DongGuk University

    collaborator OTHER
  • Inha University Hospital

    collaborator OTHER
  • Konkuk University Medical Center

    collaborator OTHER
  • Ewha Womans University

    collaborator OTHER
  • Chungnam National University Hospital

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • Memorial Sloan Kettering Cancer Center

    collaborator OTHER
  • Yale University

    collaborator OTHER
  • Mayo Clinic

    collaborator OTHER
  • University of Texas Southwestern Medical Center

    collaborator OTHER
  • University Hospitals Coventry and Warwickshire NHS Trust

    collaborator OTHER
  • Khon Kaen University

    collaborator OTHER
  • King Chulalongkorn Memorial Hospital

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Beijing Hospital

    collaborator OTHER_GOV
  • All India Institute of Medical Sciences

    collaborator OTHER
  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Hyun Joo Ahn · Department of Anesthesiology and Pain Medicine, Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-05
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06330038 on ClinicalTrials.gov